Adequacy and complications of computed tomography-guided core needle biopsy on non-small cell lung cancers for epidermal growth factor receptor mutations demonstration: 18-gauge or 20-gauge biopsy needle

Lung Cancer

Volumn 67, Issue 2, 2010, Pages 166-169

  Cheung, Yun Chung ^a,c   Chang, John Wen Cheng ^a,c   Hsieh, Jia Juan ^a,b   Lin, Gigin ^a   Tsai, Ying Huang ^a,c  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN OCEAN UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Computed tomography; CT guided transthoracic lung biopsy; EGFR mutation; Lung biopsy; Non small cell lung cancer

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER TISSUE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG TREATMENT FAILURE; FEASIBILITY STUDY; FEMALE; GENE MUTATION; HEMOPTYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LUNG BIOPSY; LUNG NON SMALL CELL CANCER; MALE; MINIMALLY INVASIVE PROCEDURE; MUTATIONAL ANALYSIS; NEEDLE BIOPSY; NUCLEOTIDE SEQUENCE; OPTICAL DENSITY; PNEUMOTHORAX; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TUMOR BLEEDING;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CARCINOMA, NON-SMALL-CELL LUNG; DNA MUTATIONAL ANALYSIS; FEMALE; HEMOPTYSIS; HEMORRHAGE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; PNEUMOTHORAX; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATIONS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SPECIMEN HANDLING; SURGERY, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 72449130415     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2009.04.007     Document Type: Article

References (21)

1. Meert A.P., Martin B., Verdebout J.M., Paesmans M., Berghmans T., Ninane V., et al. Correlation of different markers (p53, EGF-R, c-erbB-2, Ki-67) expression in the diagnostic biopsies and the corresponding resected tumors in non-small cell lung cancer. Lung Cancer 44 (2004) 295-301
2. Borczuk A.C., Shah L., Pearson G.D., Walter K.L., Wang L., Austin J.H., et al. Molecular signatures in biopsy specimens of lung cancer. Am J Respir Crit Care Med 170 (2004) 167-174
3. Molina J.R., Adjei A.A., and Jett J.R. Advances in chemotherapy of non-small cell lung cancer. Chest 130 (2006) 1211-1219
4. Lynch T.J., Bell D.W., Sordella R., Gurubhagavatula S., Okimoto R.A., Brannigan B.W., et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350 (2004) 2129-2139
5. Paez J.G., Janne P.A., Lee J.C., Tracy S., Greulich H., Gabriel S., et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304 (2004) 1497-1500
6. Fujita S., Mio T., Sonobe M., Kamiyama K., Masago K., Miyahara R., et al. Accuracy of epidermal growth factor receptor mutation analysis on the basis of small biopsy specimens in patients with nonsmall cell lung cancer. Int J Cancer 119 (2006) 1751-1752
7. Shih J.Y., Gow C.H., Yu C.J., Yang C.H., Chang Y.L., Tsai M.F., et al. Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer. Int J Cancer 118 (2006) 963-969
8. Hsieh M.H., Fang Y.F., Chang W.C., Kuo H.P., Lin S.Y., Liu H.P., et al. Complex mutation patterns of epidermal growth factor receptor gene associated with variable responses to gefitinib treatment in patients with non-small cell lung cancer. Lung Cancer 53 (2006) 311-322
9. Chen C.M., Chang J.W.C., Cheung Y.C., Lin G., Hsieh J.J., and Hsu T. Correlation of CT-guided core needle biopsy demonstrating epidermal growth factor receptor mutations to the responses of gefitinib therapy in patients with lung adenocarcinoma who failed chemotherapy: preliminary report. Acta Radiol 49 (2008) 991-994
10. Spiro S.G., and Porter J.C. Lung cancer-where are we today? Current advances in staging and nonsurgical treatment. Am J Respir Crit Care Med 166 (2002) 1166-1196
11. Pfister D.G., Johnson D.H., Azzoli C.G., Sause W., Smith T.J., Baker Jr. S., et al. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol 22 (2004) 330-353
12. Schiller J.H., Harrington D., Belani C.P., Langer C., Sandler A., Krook J., et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346 (2002) 92-98
13. Mu X.L., Li L.Y., Zhang X.T., Wang M.Z., Feng R.E., Cui Q.C., et al. Gefitinib-sensitive mutations of the epidermal growth factor receptor tyrosine kinase domain in chinese patients with non-small cell lung cancer. Clin Cancer Res 11 (2005) 4289-4294
14. Zhang X.T., Li L.Y., Mu X.L., Cui Q.C., Chang X.Y., Song W., et al. The EGFR mutation and its correlation with response of gefitinib in previously treated Chinese patients with advanced non-small-cell lung cancer. Ann Oncol 16 (2005) 1334-1342
15. Huang S.F., Liu H.P., Li L.H., Ku Y.C., Fu Y.N., Tsai H.Y., et al. High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan. Clin Cancer Res 10 (2004) 8195-8203
16. Chou T.Y., Chiu C.H., Li L.H., Hsiao C.Y., Tzen C.Y., Chang K.T., et al. Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer. Clin Cancer Res 11 (2005) 3750-3757
17. Kimura H., Fujiwara Y., Sone T., Kunitoh H., Tamura T., Kasahara K., et al. High sensitivity detection of epidermal growth factor receptor mutations in the pleural effusion of non-small cell lung cancer patients. Cancer Sci 97 (2006) 642-648
18. Kimura H., Kasahara K., Kawaishi M., Kunitoh H., Tamura T., Holloway B., et al. Detection of epidermal growth factor receptor mutations in serum as a predictor of the response to gefitinib in patients with non-small-cell lung cancer. Clin Cancer Res 12 (2006) 3915-3921
19. Hoisington D., Khairallah M., and Gonzalez-de-Leon D. Laboratory Protocols: CIMMYT Applied Biotechnology Center. second ed. (1994), CIMMYT, Mexico, D.F
20. Geraghty P.R., Kee S.T., McFarlane G., Razavi M.K., Sze D.Y., and Dake M.D. CT-guided transthoracic needle aspiration biopsy of pulmonary nodules: needle size and pneumothorax rate. Radiology 229 (2003) 475-481
21. Yeow K.M., Su I.H., Pan K.T., Tsay P.K., Lui K.W., Cheung Y.C., et al. Risk factors of pneumothorax and bleeding: multivariate analysis of 660 CT-guided coaxial cutting needle lung biopsies. Chest 126 (2004) 748-754